The present invention relates to an inclusion compound of fumagillol derivative or its salt with hydroxypropyl-.beta.-cyclodextrin or sulfobutylether-7-.beta.-cyclodextrin, and pharmaceutical compositions comprising the same. The inclusion compound according to the present invention has superior water solubility and stability while exhibiting low toxicity, rendering it valuable as an anticancer agent or inhibitor of tumor metastasis.

 
Web www.patentalert.com

< Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy

< RNAi inhibition of alpha-ENaC expression

> Methods and means for delaying seed shattering in plants

> Charged sophorolipids and sophorolipid containing compounds

~ 00608